Table 1.
TSH, FT3 and FT4 levels among males and females of studied groups
| Group | Gender | Mean ± SD | LSD | ANOVA | ||
|---|---|---|---|---|---|---|
| F-ratio | P-value | |||||
| TSH (mlu/L) | Group C (No=63) | M (33) | 2.376 ± 0.50 | ---- | 2.740 | < 0.05 |
| F (30) | 2.502 ± 0.55 | (BM, BF) | ||||
| Group B (No=42) | M (19) | 2.096 ± 0.44 | (CF, AF) | |||
| F (23) | 2.068 ± 0.32 | (CF, AF) | ||||
| Group A | M | 2.135 ± 0.29 | (AF) | |||
| F | 2.551 ± 0.37 | (BM, BF, AM) | ||||
| FT3 (ng/dl) | Group C (No=63) | M (33) | 2.14 ± 0.497 | ---- | 1.718 | NS |
| F (30) | 2.29 ± 0.650 | (BF) | ||||
| Group B (No=42) | M (19) | 1.94 ± 0.253 | ---- | |||
| F (23) | 1.74 ± 0.463 | (CF, AF) | ||||
| Group A | M | 2.07 ± 0.517 | ---- | |||
| F | 2.20 ± 0.05 | (BF) | ||||
| FT4 (ng/dl) | Group C (No=63) | M (33) | 1.09 ± 0.112 | (BF) | 2.680 | < 0.05 |
| F (30) | 1.10 ± 0.088 | (BF) | ||||
| Group B (No=42) | M (19) | 1.05 ± 0.156 | ---- | |||
| F (23) | 0.96 ± 0.168 | (CM, CF, AF) | ||||
| Group A | M | 1.03 ± 0.126 | (AF) | |||
| F | 1.14 ± 0.085 | (BF, AM) | ||||
M: male, F: Female. CM: Control group male, CF: Control group female, BM: before supplement male, BF: before supplement female, AM: After supplement male, and AF: After supplement female, NS: non-significant.